论文部分内容阅读
目的 :评估治疗骨质疏松症药品的应用现状及趋势。方法 :调查长江流域6城市136家医院1999年～2003年治疗骨质疏松症药品的销售金额、生产厂家等信息 ,并进行统计分析。结果 :1999年～2003年治疗骨质疏松症药品销售金额在药品总销售金额中的比例呈逐年下降趋势 ,品种结构呈动态变化。在治疗骨质疏松症药品中 ,钙制剂和活性维生素D类药品销售金额排序各年均居首位 ;双膦酸盐类和降钙素类药品的销售金额增幅较大 ;他汀类、选择性雌激素调节剂等新品种也有应用。结论 :治疗骨质疏松症药品的市场前景仍较广阔。
OBJECTIVE: To evaluate the status and trends of the application of drugs for the treatment of osteoporosis. Methods: To investigate the sales amount, manufacturers and other information of 136 osteoporosis drugs from 136 hospitals in 6 cities of the Yangtze River valley from 1999 to 2003, and to conduct statistical analysis. Results: From 1999 to 2003, the proportion of sales of medicines for treating osteoporosis in the total sales volume of medicines dropped year by year, and the structure of varieties showed a dynamic change. In the treatment of osteoporosis drugs, the sales volume of calcium preparations and active vitamin D drugs rank the first place each year; the sales amount of bisphosphonates and calcitonin drugs increase greatly; the statin, selectivity Estrogen regulators and other new varieties also have applications. Conclusion: There is still a wide market prospect for the treatment of osteoporosis drugs.